Skip to main content
Log in

Trends in clinical success rates

  • From the Analyst's Couch
  • Published:

From Nature Reviews Drug Discovery

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1: Trends in clinical success rates for all therapeutic areas over the past two decades.
Figure 2: Trends in clinical success rates for biologics compared with small molecules.
Figure 3: Trends in clinical success rates for partnered compounds compared with non-partnered compounds.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Katarzyna Smietana.

Ethics declarations

Competing interests

The authors of this article are employees of McKinsey & Company, a management consultancy that works with the world's leading biopharmaceutical companies on R&D productivity issues. The analysis in this study was funded by McKinsey's Pharmaceuticals and Medical Products practice and undertaken independently of any other organizations.

Supplementary information

Supplementary information S1 (box)

Data and analysis methods (PDF 126 kb)

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Smietana, K., Siatkowski, M. & Møller, M. Trends in clinical success rates. Nat Rev Drug Discov 15, 379–380 (2016). https://doi.org/10.1038/nrd.2016.85

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd.2016.85

  • Springer Nature Limited

This article is cited by

Navigation